Investigating brain stimulation to treat anxiety in PTSD patients

Targeting the Default Mode Network: A TMS-fMRI Study

NIH-funded research Palo Alto Veterans Instit for Research · NIH-10763397

This study is looking at how a special treatment called rTMS can help reduce anxiety in people with PTSD by targeting specific areas of the brain, and it’s designed for those who want to find new ways to feel better after experiencing trauma.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionPalo Alto Veterans Instit for Research NIH-funded
Lab location1 site (Palo Alto, United States)
Project IDNIH-10763397 on NIH RePORTER

What this research studies

This research explores how targeting specific brain networks, particularly the default mode network (DMN), can help alleviate anxiety symptoms in individuals with post-traumatic stress disorder (PTSD). Using a technique called repetitive transcranial magnetic stimulation (rTMS), the study aims to modulate brain activity in areas associated with anxiety and traumatic memories. By focusing on the left hemisphere of the brain, the researchers hope to discover new ways to improve treatment outcomes for PTSD patients. Participants will undergo rTMS sessions while their brain activity is monitored using functional MRI (fMRI) to assess the effects of the stimulation.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with PTSD who experience significant anxiety symptoms.

Not a fit: Patients who do not have PTSD or those whose anxiety symptoms are not related to traumatic experiences may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for anxiety symptoms in PTSD patients.

How similar studies have performed: While this approach is novel in targeting the DMN for PTSD treatment, previous studies have shown success in using rTMS for other mental health conditions, indicating potential for positive outcomes.

Where this research is happening

Palo Alto, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.